Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory Therapy in Patients Diagnosed With COVID-19 Disease

NCT04412395 is registered in ClinicalTrials.gov with National Research Centre, Egypt as lead sponsor.

NCT NCT04412395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04412395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory Therapy in Patients Diagnosed With COVID-19 Disease
Lead sponsor
National Research Centre, Egypt
Phase
Phase 2
Overall status
Unknown status
Start date
February 1, 2022
Completion date
December 30, 2022
Enrollment
516 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, corona virus infection, coronavirus infection, covid-19, middle east respiratory syndrome (mers), sars-cov 2